Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000525510 | SCV000651008 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001572548 | SCV001797208 | likely benign | not provided | 2021-05-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358569 | SCV002621081 | likely benign | Cardiovascular phenotype | 2020-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001572548 | SCV003917563 | likely benign | not provided | 2025-04-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |